Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

520-68-3

(+)-Echimidine

520-68-3
41093-89-4

Echimidine N-Oxide

41093-89-4
65582-53-8

Europine N-oxide

65582-53-8
101342-45-4

4-Epichlortetracycline HCl

101342-45-4
153773-82-1

Ertapenem sodium

153773-82-1
1070-11-7

Ethambutol 2HCl

1070-11-7
33419-42-0

Etoposide

33419-42-0
56390-09-1

Epirubicine HCl

56390-09-1
84294-96-2

Enoxacin sesquihydrate

84294-96-2
144143-96-4

Eprosartan mesylate

144143-96-4
107868-30-4

Exemestan

107868-30-4
4999-79-5

17beta-Estradiol 3-O-SulfateSodium Salt

4999-79-5
236395-14-5

Eslicarbazepine Acetate

236395-14-5
84611-23-4

Erdosteine

84611-23-4
31161-17-8

EDDP Perchlorate

31161-17-8
NA

Erythromycin D3

NA
66789-03-5

17beta-Estradiol-2,4,16,16 D4

66789-03-5
481-29-8

Epiandrosterone

481-29-8
60207-93-4

Etaconazole

60207-93-4
219861-08-2

(S)-Citalopram Oxalate - Escitalopram

219861-08-2